English (United States)

EFGCP Paediatrics Masterclass, London

reduce font Size enlarge font Size print content

EFGCP Paediatrics Masterclass

Paediatric Drug Development & the Paediatric Investigation Plan (PIP): Background, Operational Challenges, Negotiation Strategy 

29 September 2014

Aloft London Excel Hotel, London, United Kingdom

Without a paediatric investigation plan (PIP) no new drugs can anymore be registered in the EU. Historical background of paediatric pharmaceutical legislation in the US and EU, the PIP procedure, basics in child physiology and paediatric drug development will be outlined, including an interactive walk through the EMA website.

Who should attend?

If you are involved in drug development, you need a basic understanding of paediatric drug development. This regards all levels of drug development from operationally running or supervising clinical trials to top management positions that have a key decision authority in drug development.

More information: www.luxclin.lu/Events/Details/?c=EVT4684CPT

Who should register?

Healthcare professionals who wish to be part of a unique network, providing access to up-to-date, accurate and validated information about clinical research.

Investigators and study staff who wish to be part of a unique network, in order to stay abreast of clinical trials taking place in Luxembourg and who are willing to further develop their competencies.